BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32492897)

  • 1. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults.
    Zhang WB; Aleksic S; Gao T; Weiss EF; Demetriou E; Verghese J; Holtzer R; Barzilai N; Milman S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort.
    Kaplan RC; Strizich G; Aneke-Nash C; Dominguez-Islas C; Bužková P; Strickler H; Rohan T; Pollak M; Kuller L; Kizer JR; Cappola A; Li CI; Psaty BM; Newman A
    J Clin Endocrinol Metab; 2017 Jan; 102(1):267-278. PubMed ID: 27820656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study.
    Kaplan RC; Bùzková P; Cappola AR; Strickler HD; McGinn AP; Mercer LD; Arnold AM; Pollak MN; Newman AB
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1970-6. PubMed ID: 22442270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and insulin-like growth factors in the Cardiovascular Health Study.
    Shah N; Rice T; Tracy D; Rohan T; Bůžková P; Newman A; Kaplan RC
    J Clin Sleep Med; 2013 Dec; 9(12):1245-51. PubMed ID: 24340285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.
    Hu D; Pawlikowska L; Kanaya A; Hsueh WC; Colbert L; Newman AB; Satterfield S; Rosen C; Cummings SR; Harris TB; Ziv E;
    J Am Geriatr Soc; 2009 Jul; 57(7):1213-8. PubMed ID: 19558480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes.
    van Dijk PR; Logtenberg SJ; Chisalita SI; Hedman CA; Groenier KH; Gans RO; Kleefstra N; Arnqvist HJ; Bilo HJ
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2493-501. PubMed ID: 27115061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    Am Heart J; 2008 Jun; 155(6):1006-12. PubMed ID: 18513511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults.
    Aneke-Nash CS; Parrinello CM; Rajpathak SN; Rohan TE; Strotmeyer ES; Kritchevsky SB; Psaty BM; Bůžková P; Kizer JR; Newman AB; Strickler HD; Kaplan RC
    J Am Geriatr Soc; 2015 May; 63(5):902-9. PubMed ID: 25989565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.
    Duggan C; Wang CY; Neuhouser ML; Xiao L; Smith AW; Reding KW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
    Int J Cancer; 2013 Mar; 132(5):1191-200. PubMed ID: 22847383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 bioactivity plays a prosurvival role in older participants.
    Maggio M; Cattabiani C; Lauretani F; Bandinelli S; De Vita F; Dall'Aglio E; Corsonello A; Lattanzio F; Paolisso G; Ferrucci L; Ceda GP
    J Gerontol A Biol Sci Med Sci; 2013 Nov; 68(11):1342-50. PubMed ID: 23671288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.